Scientific Program
The program will consist of keynote and invited speakers. The following topics will be covered:
- Advances in virology research: Human and Animal Perspectives
- Innovative technological platforms in virus research: Novel vaccines and beyond
- Translation of research knowledge to application
- Shared experience from both developers and users
Tentative Program
Day I: 12 February 2018 | ||
Session I: Overview and Update in Virology Research: Human and Animal Perspectives | ||
08.30 – 09.00 |
Registration |
|
09.00 – 09.10 |
Opening Ceremony |
|
09.10 – 10.00 |
Keynote: |
|
10.00 – 10.30 |
Coffee break |
|
10.30 – 11.15 |
Control of avian diseases: Challenges and opportunities |
|
11.15 – 12.00 |
Preventive measures in Poultry and Swine farming in Thailand |
|
12.00 – 13.00 |
Lunch |
|
Session II: Innovative Technological Platforms in Virus Research: Novel Vaccines and Beyond | ||
13.00 – 13.40 |
Identification of viral targets of host T cell immunity for development of swine vaccines |
|
13.40 – 14.20 |
Comparative analyses of proteomics and genomic characterization between virulent and attenuated PEDV |
|
14.20 – 15.00 |
Coffee break |
|
15.00 – 15.40 |
Genetic manipulation of Porcine Epidemic Diarrhea Virus (PEDV): Translating basic science to effective vaccines By Dr. Anan Jongkaewwattana National Center for Genetic Engineering and Biotechnology, Thailand |
|
15.40 – 16.20 |
Avian influenza vaccines |
|
Day II: 13 February 2018 | ||
Session III: Innovative Technological Platforms in Virus Research: New trends of technology | ||
08.30 – 09.00 |
Registration |
|
09.00 – 09.40 |
Streamlining the production of recombinant proteins for structural proteomics By Prof. Ray Owens University of Oxford, UK |
|
09.40 – 10.20 |
Manufacturing the future Global Health Challenge at less than $1a dose |
|
10.20 – 10.40 |
Coffee break |
|
10.40 – 11.20 |
Targeted yeast ghosts as novel oral vaccine platform to combat enteric diseases in swine |
|
11.20 – 12.00 |
Measles: Can we use a human baby vaccine for veterinary purposes? |
|
12.00 – 13.00 |
Lunch |
|
Session IV: Translation of Research Knowledge to Applications | ||
13.00 – 13.40 |
Therapeutic and diagnostic monoclonal antibodies for Human and animal viruses |
|
13.40 – 14.20 |
Host cell engineering for veterinary virus propagation |
|
14.20 – 15.00 |
Study of host-virus interaction and application for development of a new class anti-viral drug |
|
15.00 – 15.30 |
Coffee break |
|
15.30 – 16.10 |
Retooling viral nucleocapsid proteins for combatting viruses |
|
16.10 – 16.40 |
Synthesis: Summary of the symposium |